Mwandishi
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
Jumatano, 15 Julai 2026, 2:43:25 GMT +3
Antiretrovirals (ARVs) medicine lists
Antiretrovirals (ARVs) medicine lists
Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
Name of drug | Dosage forms and Strengths | Level of medicine |
Abacavir (ABC) | Tablet: 300mg (as sulfate) | A |
Lamivudine (3TC) | Oral Liquid 50mg/mL; Tablet: 150mg | A |
Tenofovir disoproxil fumarate (TDF) | Tablet: 300mg | A |
Zidovuine (AZT) | Capsule 250mg; Oral liquid 50mg/5mL | A |
Non-nucleoside Transcriptase Inhibitors
Name of drug | Dosage forms and Strengths | Level of medicine |
Efavirenz (EFV) | Tablet: 200mg; 600mg | A |
Nevirapine (NVP) | Oral liquid: 50mg/5mL; Tablet 50mg (dispersible); 200mg | A |
Protease Inhibitors
Name of drug | Dosage forms and Strengths | Level of medicine |
Atazanavir | Tablet 100mg; 300mg (as sulfate) | C |
Atazanavir + Ritonavir | Tablet: 300mg (as sulfate) + 100mg | C |
Lopinavir + Ritonavir (LPV/r) | Capsule 40mg + 10mg; Oral liquid 400mg + 100mg/5mL; Tablet 100mg + 25mg; 200mg + 50mg | C |
Ritonavir | Oral liquid 400mg/5mL; Tablet 25mg; 100mg | C |
Darunavir | Tablet 75mg, 400mg, 600mg, 800mg | S |
Integrase Inhibitors
Name of drug | Dosage forms and Strengths | Level of medicine |
Raltegravir | Tablet 25mg, 100mg, 400mg | S |
Fixed Dose Combinations
Name of drug | Dosage forms and Strengths | Level of medicine |
Abacavir/Lamivudine | Dispersible Tablet 60/30mg; Dispersible tablet; 120/60mg; Tablet 600/300mg Scored | A |
Tenofovir /Emtricitabine | Tablet 300/200mg | A |
Tenofovir/Emtricitabine/Efavirenz | Tablet 300/200/600mg | A |
Tenofovir/Lamivudine/Efavirenz | Tablet 300/300/600mg | A |
Tenofovir/Lamivudine/Dolutegravir | Dispersible tablet 60/30mg; Tablet 300/300/50mg | A |
Zidovudine/Lamivudine | Tablet 300/150mg | A |
Zidovudine/Lamivudine/Nevirapine | Tablet 300/150/200mg | A |
Imeandikwa:
Jumatano, 3 Juni 2026, 18:35:44 GMT +3
References: